Investigating the effect of celecoxib on the treatment of bipolar disorder

Phase 3

Recruiting

• Conditions: Bipolar Disorder.; Bipolar disorder, current episode manic severe with psychotic features; F31.2

• Registration Number: IRCT20221216056832N1
• Lead Sponsor: Babol University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Having bipolar disorder
Age above 18 years

Exclusion Criteria

History of dementia
Existence of serious cardiovascular and kidney disease
Consumption of substances except for smoking and caffeine

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Bipolar affective disorde. Timepoint: 2, 4 and 8 weeks after starting celecoxib. Method of measurement: Young mania questionnaire.